Stutsky explains why shifting therapy perceptions had more pharmacist touchpoints and longer time on therapy among patients with ATTR-CM.
|Articles|March 28, 2011
HIT Press Club AJMC - Audience Q&A Session with the Panelists
Author(s)Sachin Jain, MD, MBA
The Q&A Session from the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Advertisement
The Q&A Session from the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
NEI Director Highlights Pediatric Advances, AI’s Promise in Eye Care
3
GLP-1s Have Protective Benefit Against DME, Glaucoma Surgery
4
Keynote Address Tackles AI’s Role in Health Care, Eye Care
5